New Orleans - Vaccination with a mixture of 12 peptides was immunogenic in 100 percent of melanoma patients tested, even with multiple peptides competing for the same cell surface binding sites, according to Craig L. Slingluff, Jr., M.D.
The Weekly Roundup: July 22-26
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Emerging Therapeutic for Non-Segmental Vitiligo: Merck’s MK-6194
The Cutaneous Connection: Enhancing Vitiligo Care With Nanette Silverberg, MD
Study Highlights Efficacy of Lotion with Biotechnological Phytocomplex, Niacinamide, and Succinic Acid in Enhancing Microbiota Diversity and Reducing Acne Severity
The FDA Approves Deuruxolitinib for Severe Alopecia in Adults